Research to reduce cancer risk and improve care for patients
Official title: Cancer Prevention and Control Research Program
Funded at University of Rochester · NIH-11014530 · Data updated 2026-11-12
This study is looking for ways to help people at high risk for cancer and improve the care and support for those already facing cancer, making their journey a little easier and better.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project start | March 15, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $39,276 |
| NIH project number | 1P30CA272302-01A1 |
| Project ID | NIH-11014530 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at high risk for cancer, cancer patients, survivors, and their caregivers.
✕Less likely to help
Patients with no history of cancer or those who are not at risk for cancer may not benefit from this research.
What this research studies
The Cancer Prevention and Control Research Program at the Wilmot Cancer Institute focuses on decreasing the burden of cancer and improving the quality of life for patients affected by cancer. This program conducts innovative research aimed at identifying effective interventions for individuals at high risk of cancer, developing supportive care therapies for patients and survivors, and enhancing the delivery of supportive care in healthcare systems. By employing a transdisciplinary approach, the program addresses various aspects of cancer prevention and treatment, ensuring comprehensive care for patients throughout their cancer journey.
Why it matters
Potential benefit: If successful, this research could lead to significant reductions in cancer risk and improved supportive care for patients undergoing treatment.
How similar studies have gone: Previous research in cancer prevention and supportive care has shown promising results, indicating that this approach is both relevant and potentially impactful.
Where this research is happening
-
University of Rochester
Rochester, United States Active
Researchers
- Principal investigator: Mustian, Karen M. — University of Rochester
- Study coordinator: Mustian, Karen M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.